Everest Biolabs
PrivateLast Round
Seed
Feb 25, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Everest Biolabs operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. It was founded in 2024.
Everest Biolabs is a life sciences company that provides automated instruments and assay kits for extracellular vesicle and exosome isolation and analytics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Everest Biolabs Comparables
Compare Everest Biolabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exodus Bio | 84% | |
| Cell Guidance Systems | 82% | |
| LabSpinner | 79% |
For institutional investors. Book with your work email.
Everest Biolabs Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Everest Biolabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MassVentures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 97% MoM.
- Jun 25, 2026
Monthly visitors increased 109% MoM, reaching 2.2K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 25, 2026
Everest Biolabs receives a $2.1M Small Business Innovation Research grant from the National Institute of General Medical Sciences on Sep 25th '26 to develop automated, plate-based tools that combine size-exclusion chromatography with affinity-based contaminant depletion, adapt the approach to 24-well plates, and validate higher-throughput processing through Aug '28.
- receives_financingSep 25, 2026
Everest Biolabs received financing of $2.1M in Small Business Innovation Research grant on Sep 1st '26.
- launchesSep 24, 2026
Everest Biolabs has launched the Ascent and Summit instruments for automated EV isolation since Nov '24, expanding its tools for scalable EV research.
- receives_awardSep 24, 2026
Everest Biolabs is selected for a Direct-to-Phase II award funded by the National Institute of General Medical Sciences to advance scalable, standardized extracellular vesicle isolation technology.
For institutional investors. Book with your work email.
Everest Biolabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Everest Biolabs's valuation, stock price, and market status.
Is Everest Biolabs a public or private company?
Everest Biolabs is a private company.
What is the current stock price of Everest Biolabs?
Everest Biolabs is a private company, so its shares have no public market price. Caplight tracks Everest Biolabs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Everest Biolabs worth (valuation)?
Valuation information for Everest Biolabs is not publicly available.
Can I buy Everest Biolabs stock?
Everest Biolabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Everest Biolabs's last funding round?
Everest Biolabs's most recent funding round was Seed on February 25, 2026.
Who are the main investors in Everest Biolabs?
Key investors in Everest Biolabs include MassVentures.
Will Everest Biolabs IPO soon?
No public IPO plans have been announced for Everest Biolabs.
How can I track Everest Biolabs secondary market activity?
Caplight tracks bids, offers, and trades in Everest Biolabs's shares on secondary markets.